| Literature DB >> 21916574 |
Mitchel Barry1, Virgilio Sacchini.
Abstract
Contralateral mastectomy, in the setting of unilateral breast cancer, may only offer a survival benefit in selected patients. In fact, most women with a unilateral breast cancer will never develop a contralateral breast cancer. Despite this, there is a rapidly increasing trend of patients undergoing contralateral prophylactic mastectomy. The Society of Surgical Oncology has provided relative clinical indications for this prophylactic procedure; however, there are other clinical and more important patient factors that are relevant to the decision. In this article, we discuss the indications for this controversial procedure and also explore the patient's motivation to undergo this preventative measure. Nevertheless, the decision to perform a contralateral mastectomy should include a multidisciplinary team approach in conjunction with a patient who has been appropriately informed regarding the risks, benefits and alternatives of this procedure.Entities:
Mesh:
Year: 2011 PMID: 21916574 DOI: 10.1586/era.11.100
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN: 1473-7140 Impact factor: 4.512